A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the ...

Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...

Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...

The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...

The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss ...

Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...

The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza ...

FP008 is designed for patients with solid tumors that have not responded to existing immunotherapies targeting PD-1.

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...